Skip to main content

3 Result(s)

within Mark A. Moyad Remove this filter Cardiology Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Open Access

    Correction to: Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial

    The article ‘‘Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial’’, written by Mark A. Moyad, Larry E. Robinso...

    Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud… in Advances in Therapy (2019)

    Download PDF (174 KB) View Article

  2. Article

    Open Access

    Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial

    Allergic rhinitis (AR) impacts around 25% of the worldwide population. However, cost, safety, and a high dissatisfaction rate with numerous conventional medications continues to be an issue in the largest pati...

    Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud… in Advances in Therapy (2009)

    Download PDF (615 KB)

  3. No Access

    Article

    Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations

    The objective of this study was to test the effects of acute doses of vitamin C alone, calcium ascorbate with vitamin C metabolites, and placebo, on total plasma and leukocyte vitamin C concentrations over 24 ...

    Mark A. Moyad, Maile A. Combs, Angelica S. Vrablic, Janet Velasquez… in Advances in Therapy (2008)